{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:28:07Z","timestamp":1785439687879,"version":"3.56.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10792-020-01620-0","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T04:10:56Z","timestamp":1603167056000},"page":"753-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices"],"prefix":"10.1007","volume":"41","author":[{"given":"Yamini","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-9932","authenticated-orcid":false,"given":"Niharika","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"1620_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi LA, Sorenson J, Spaide RF et al (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10:1\u20138","journal-title":"Retina"},{"key":"1620_CR2","first-page":"110","volume":"94","author":"RC Kleiner","year":"1984","unstructured":"Kleiner RC, Brucker AJ, Johnson RL (1984) Posterior uveal bleeding syndrome. Ophthalmology 94:110","journal-title":"Ophthalmology"},{"key":"1620_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9394(85)90682-8","volume":"100","author":"RM Stern","year":"1985","unstructured":"Stern RM, Zakov ZN, Zegarra H et al (1985) Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol 100:560\u2013569","journal-title":"Am J Ophthalmol"},{"key":"1620_CR4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archopht.1997.01100150480005","volume":"115","author":"LA Yannuzzi","year":"1997","unstructured":"Yannuzzi LA, Ciardella A, Spaide RF et al (1997) The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115:478\u2013485","journal-title":"Arch Ophthalmol"},{"key":"1620_CR5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/archopht.117.11.1503","volume":"117","author":"LA Yannuzzi","year":"1999","unstructured":"Yannuzzi LA, Wong DW, Sforzolini BS et al (1999) Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 117:1503\u20131510","journal-title":"Arch Ophthalmol"},{"key":"1620_CR6","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1167\/iovs.14-16236","volume":"56","author":"G Coscas","year":"2015","unstructured":"Coscas G, Lupidi M, Coscas F et al (2015) Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest Ophthalmol Vis Sci 56:3187\u20133195","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1620_CR7","first-page":"650","volume":"20","author":"BA Lafaut","year":"2000","unstructured":"Lafaut BA, Aisenbrey S, VandenBroecke C et al (2000) Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 20:650\u2013654","journal-title":"Retina"},{"key":"1620_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006982-199414020-00007","volume":"14","author":"MW MacCumber","year":"1994","unstructured":"MacCumber MW, Dastgheib K, Bressler NM et al (1994) Clinicopathologic correlation of the multiple recurrent serosanguineous retinal pigment epithelial detachments syndrome. Retina 14:143\u2013152","journal-title":"Retina"},{"key":"1620_CR9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjo.86.10.1093","volume":"86","author":"A Okubo","year":"2002","unstructured":"Okubo A, Sameshima M, Uemura A et al (2002) Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 86:1093\u20131098","journal-title":"Br J Ophthalmol"},{"key":"1620_CR10","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1167\/iovs.08-2134","volume":"49","author":"H Nakashizuka","year":"2008","unstructured":"Nakashizuka H, Mitsumata M, Okisaka S et al (2008) Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 49:4729\u20134737","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1620_CR11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archopht.120.4.502","volume":"120","author":"RH Rosa Jr","year":"2002","unstructured":"Rosa RH Jr, Davis JL, Eifrig CW (2002) Clinicopathologic reports, case reports and small case series:clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 120(4):502\u2013508","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"1620_CR12","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1167\/iovs.08-2134","volume":"49","author":"H Nakashizuka","year":"2008","unstructured":"Nakashizuka H, Mitsumata M, Okisaka S et al (2008) Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 49(11):4729\u20134737","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1620_CR13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajo.2013.04.001","volume":"156","author":"MY Lee","year":"2013","unstructured":"Lee MY, Lee WK, Back J et al (2013) Photodynamic theory versus combination theory in polypoidal choroidal vasculopathy:changes of aqueous vascular endothelial growth factor. Am J Ophthalmol 156(2):343\u2013348","journal-title":"Am J Ophthalmol"},{"key":"1620_CR14","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.18632\/aging.101329","volume":"9","author":"Y Subhi","year":"2017","unstructured":"Subhi Y, Nielsen MK, Molbech CR et al (2017) T-cell differentiation and CD56\u2009+\u2009levels in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Aging 9:2436\u20132452","journal-title":"Aging"},{"key":"1620_CR15","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/IAE.0000000000001346","volume":"36","author":"WK Lee","year":"2016","unstructured":"Lee WK, Back J, Dansingani KK et al (2016) Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal choroidal thickness. Retina 36:S73\u2013S82","journal-title":"Retina"},{"key":"1620_CR16","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.ajpath.2017.08.025","volume":"187","author":"S Kumar","year":"2017","unstructured":"Kumar S, Nakashizuka H, Jones A et al (2017) Proteolytic degradation and inflammation play critical roles in polypoidal choroidal vasculopathy. Am J Pathol 187:2841\u20132857","journal-title":"Am J Pathol"},{"key":"1620_CR17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/ceo.13152","volume":"46","author":"Y Subhi","year":"2018","unstructured":"Subhi Y, Krogh Nielsen M, Molbech CR et al (2018) Altered proportion of CCR2+\u2009and CX3CR1+\u2009circulating monocytes in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Clin Exp Ophthalmol 46:661\u2013669","journal-title":"Clin Exp Ophthalmol"},{"key":"1620_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00592-009-0127-2","volume":"47","author":"P Kubisz","year":"2010","unstructured":"Kubisz P, Chudy P, Stasko J et al (2010) Circulating vascular endothelial growth factor in the normo- and\/or microalbuminuric patients with type 2 diabetes mellitus. Acta Diabetol 47:119\u2013124","journal-title":"Acta Diabetol"},{"key":"1620_CR19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/IAE.0b013e31826ffe9d","volume":"33","author":"Y Sakurada","year":"2013","unstructured":"Sakurada Y, Yoneyama S, Imasawa M et al (2013) Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular agerelated macular degeneration. Retina 33:841\u2013845","journal-title":"Retina"},{"key":"1620_CR20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/eye.2000.186","volume":"14","author":"PL Lip","year":"2000","unstructured":"Lip PL, Hope-Ross MW, Gibson JM (2000) Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations. Eye 14:695\u2013700","journal-title":"Eye"},{"key":"1620_CR21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ophtha.2010.09.026","volume":"118","author":"P Cackett","year":"2011","unstructured":"Cackett P, Yeo I, Cheung CM et al (2011) Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology 118:846\u2013852","journal-title":"Ophthalmology"},{"key":"1620_CR22","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.ophtha.2009.06.013","volume":"116","author":"T Ueta","year":"2009","unstructured":"Ueta T, Obata R, Inoue Y et al (2009) Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 116:2400\u20132406","journal-title":"Ophthalmology"},{"key":"1620_CR23","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/eye.2010.86","volume":"24","author":"RA Mahdy","year":"2010","unstructured":"Mahdy RA, Nada WM, Hadhoud KM et al (2010) The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye 24:1576\u20131584","journal-title":"Eye"},{"key":"1620_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3341\/kjo.2012.26.1.15","volume":"26","author":"HS Park","year":"2012","unstructured":"Park HS, Kim IT (2012) Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretinopathy. Korean J Ophthalmol 26:15\u201320","journal-title":"Korean J Ophthalmol"},{"key":"1620_CR25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0161-6420(00)00614-X","volume":"108","author":"RM Ahuja","year":"2001","unstructured":"Ahuja RM, Downes SM, Stanga PE et al (2001) Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 108:1009\u20131010","journal-title":"Ophthalmology"},{"key":"1620_CR26","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.ophtha.2006.12.021","volume":"114","author":"M Kikuchi","year":"2007","unstructured":"Kikuchi M, Nakamura M, Ishikawa K et al (2007) Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 114:1722\u20131727","journal-title":"Ophthalmology"},{"key":"1620_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/aos.13886","volume":"97","author":"Y Subhi","year":"2019","unstructured":"Subhi Y, Krogh Nielsen M, Molbech CR et al (2019) Plasma markers of chronic lowgrade inflammation in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Acta Ophthalmol 97:99\u2013106","journal-title":"Acta Ophthalmol"},{"key":"1620_CR28","doi-asserted-by":"crossref","first-page":"e110818","DOI":"10.1371\/journal.pone.0110818","volume":"9","author":"H-C Cheng","year":"2014","unstructured":"Cheng H-C, Liu J-H, Lee S-M et al (2014) Hyperhomocysteinemia in patients with polypoidal choroidal vasculopathy: a case control study. PLoS ONE 9:e110818","journal-title":"PLoS ONE"},{"key":"1620_CR29","first-page":"219","volume":"39","author":"KS McCully","year":"2009","unstructured":"McCully KS (2009) Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann Clin Lab Sci 39:219\u2013232","journal-title":"Ann Clin Lab Sci"},{"key":"1620_CR30","first-page":"729","volume":"19","author":"R Zeng","year":"2013","unstructured":"Zeng R, Wen F, Zhang X et al (2013) Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration. Mol Vis 19:729\u2013736","journal-title":"Mol Vis"},{"key":"1620_CR31","first-page":"4","volume":"28","author":"Y Tao","year":"2012","unstructured":"Tao Y, Hu J, Li XX (2012) Clinical characteristics of 254 cases of polypoidal choroidal vasculopathy. Chin J Ocular Fundus Dis 28:4","journal-title":"Chin J Ocular Fundus Dis"},{"key":"1620_CR32","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","volume":"121","author":"K Sho","year":"2003","unstructured":"Sho K, Takahashi K, Yamada H et al (2003) Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 121:1392\u20131396","journal-title":"Arch Ophthalmol"},{"key":"1620_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.eye.6700706","volume":"18","author":"ID Ladas","year":"2004","unstructured":"Ladas ID, Rouvas AA, Moschos MM et al (2004) Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye 18:455\u2013459","journal-title":"Eye"},{"key":"1620_CR34","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/bjophthalmol-2016-310074","volume":"101","author":"S Yadav","year":"2017","unstructured":"Yadav S, Parry DG, Beare NAV et al (2017) Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians. Br J Ophthalmol 101:1377\u20131380","journal-title":"Br J Ophthalmol"},{"key":"1620_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-007-0498-2","volume":"52","author":"SH Byeon","year":"2008","unstructured":"Byeon SH, Lee SC, Oh H-S et al (2008) Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 52:57\u201362","journal-title":"Jpn J Ophthalmol"},{"key":"1620_CR36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4103\/0301-4738.67052","volume":"58","author":"G Anantharaman","year":"2010","unstructured":"Anantharaman G, Ramkumar G, Gopalakrishnan M, Rajput A (2010) Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients. Indian J Ophthalmol 58:399\u2013405","journal-title":"Indian J Ophthalmol"},{"key":"1620_CR37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.survophthal.2010.03.004","volume":"55","author":"Y Imamura","year":"2010","unstructured":"Imamura Y, Engelbert M, Iida T, Freund KB, Yannuzzi LA (2010) Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol 55:501\u2013515","journal-title":"Surv Ophthalmol"},{"key":"1620_CR38","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/IAE.0000000000001872","volume":"38","author":"TD Lorentzen","year":"2018","unstructured":"Lorentzen TD, Subhi Y, Sorensen TL (2018) Prevalence of polypoidal choroidal vasculopathy in white patients with exudative age-related macular degeneration: systematic review and meta-analysis. Retina 38:2363\u20132371","journal-title":"Retina"},{"key":"1620_CR39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","volume":"49","author":"AP Ciardella","year":"2004","unstructured":"Ciardella AP, Donsoff IM, Huang SJ et al (2004) Polypoidal choroidal vasculopathy. Surv Ophthalmol 49:25\u201337","journal-title":"Surv Ophthalmol"},{"key":"1620_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000355488","volume":"231","author":"S Honda","year":"2014","unstructured":"Honda S, Matsumiya W, Negi A (2014) Polypoidal choroidal vasculopathy: clinical features and genetic predisposition. Ophthalmologica 231:59\u201374","journal-title":"Ophthalmologica"},{"key":"1620_CR41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","volume":"133","author":"M Uyama","year":"2002","unstructured":"Uyama M, Wada M, Nagai Y et al (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639\u2013648","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1620_CR42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10792-016-0351-z","volume":"37","author":"CS Tan","year":"2016","unstructured":"Tan CS, Lim LW, Ngo WK (2016) Treatment of massive subretinal hemorrhage from polypoidal choroidal vasculopathy and age-related macular degeneration. Int Ophthalmol 37(4):779\u2013780","journal-title":"Int Ophthalmol"},{"key":"1620_CR43","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0161-6420(98)98016-2","volume":"105","author":"RS Moorthy","year":"1998","unstructured":"Moorthy RS, Lyon AT, Rabb MF et al (1998) Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology 105:1380\u20131385","journal-title":"Ophthalmology"},{"key":"1620_CR44","first-page":"382","volume":"116","author":"LA Yannuzzi","year":"1998","unstructured":"Yannuzzi LA, Nogueira FB, Spaide RF et al (1998) Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. Arch Ophthalmol 116:382\u2013383","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1620_CR45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9394(99)00436-5","volume":"129","author":"RE Smith","year":"2000","unstructured":"Smith RE, Wise K, Kingsley RM (2000) Idiopathic polypoidal choroidal vasculopathy and sickle cell retinopathy. Am J Ophthalmol 129(4):544\u2013546","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1620_CR46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00006982-200108000-00024","volume":"21","author":"HM Bartlett","year":"2001","unstructured":"Bartlett HM, Willoughby B, Mandava N (2001) Idiopathic polypoidal choroidal vasculopathy in a patient with melanocytoma of the optic nerve. Retina 21(4):396\u2013399","journal-title":"Retina"},{"issue":"6","key":"1620_CR47","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajo.2006.06.063","volume":"142","author":"M Mauget-Faysse","year":"2006","unstructured":"Mauget-Faysse M, Cornut PL, Quaranta El-Maftouhi M et al (2006) Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma. Am J Ophthalmol 142(6):970\u2013975","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1620_CR48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00006982-200408000-00026","volume":"24","author":"H Li","year":"2004","unstructured":"Li H, Wen F, Wu D (2004) Polypoidal choroidal vasculopathy in a patient with circumscribed choroidal hemangioma. Retina. 24(4):629\u2013631","journal-title":"Retina."},{"key":"1620_CR49","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","volume":"238","author":"BA Lafaut","year":"2000","unstructured":"Lafaut BA, Leys AM, Snyers B et al (2000) Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 238:752\u2013759","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1620_CR50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/OPTH.S126226","volume":"11","author":"C Bhoomibunchoo","year":"2017","unstructured":"Bhoomibunchoo C, Yospaiboon Y, Thoongsuwan S et al (2017) Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization. Clin Ophthalmol 11:317\u2013322","journal-title":"Clin Ophthalmol"},{"key":"1620_CR51","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00417-007-0564-y","volume":"245","author":"F Gomi","year":"2007","unstructured":"Gomi F, Sawa M, Mitarai K et al (2007) Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 245:1421\u20131427","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1620_CR52","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/bjophthalmol-2014-305059","volume":"98","author":"CSH Tan","year":"2014","unstructured":"Tan CSH, Ngo WK, Lim LW et al (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98:1528\u20131533","journal-title":"Br J Ophthalmol"},{"key":"1620_CR53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4103\/ijo.IJO_1136_17","volume":"66","author":"G Anantharaman","year":"2018","unstructured":"Anantharaman G, Sheth J, Bhende M, Narayanan R, Natarajan S, Rajendran A et al (2018) Polypoidal choroidal vasculopathy: pearls in diagnosis and management. Indian J Ophthalmol 66:896\u2013908","journal-title":"Indian J Ophthalmol"},{"key":"1620_CR54","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","volume":"33","author":"AH Koh","year":"2013","unstructured":"Koh AH, Expert PCVP, Chen LJ, Chen SJ, Chen Y, Giridhar A, Iida T et al (2013) Polypoidal choroidal vasculopathy: evidence\u2013based guidelines for clinical diagnosis and treatment. Retina 33:686\u2013716","journal-title":"Retina"},{"issue":"1","key":"1620_CR55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","volume":"92","author":"F Gomi","year":"2008","unstructured":"Gomi F, Sawa M, Sakaguchi H et al (2008) Efficacy of intravitreal bevacizumab for choroidal vasculopathy. Br J Ophthalmol 92(1):70\u201373","journal-title":"Br J Ophthalmol"},{"issue":"Suppl. 1","key":"1620_CR56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/IAE.0b013e31823f9b97","volume":"32","author":"RF Spaide","year":"2012","unstructured":"Spaide RF, Donsoff I, Lam DL et al (2012) Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina 32(Suppl. 1):529\u2013535","journal-title":"Retina"},{"key":"1620_CR57","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.ophtha.2003.12.056","volume":"111","author":"W-M Chan","year":"2004","unstructured":"Chan W-M, Lam DSC, Lai TYY et al (2004) Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 111:1576\u20131584","journal-title":"Ophthalmology"},{"key":"1620_CR58","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00417-005-1139-4","volume":"243","author":"RM Silva","year":"2005","unstructured":"Silva RM, Figueira J, Cachulo ML et al (2005) Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 243:973\u2013979","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1620_CR59","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10384-007-0452-3","volume":"51","author":"E Akaza","year":"2007","unstructured":"Akaza E, Yuzawa M, Matsumoto Y et al (2007) Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol 51:270\u2013277","journal-title":"Jpn J Ophthalmol"},{"key":"1620_CR60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2007.03.014","volume":"144","author":"A Otani","year":"2007","unstructured":"Otani A, Sasahara M, Yodoi Y et al (2007) Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 144:7\u201314","journal-title":"Am J Ophthalmol"},{"key":"1620_CR61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000076844","volume":"218","author":"SC Lee","year":"2004","unstructured":"Lee SC, Seong YS, Kim SS et al (2004) Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula. Ophthalmologica 218:193\u2013201","journal-title":"Ophthalmologica"},{"key":"1620_CR62","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajo.2008.05.025","volume":"146","author":"Y Kurashige","year":"2008","unstructured":"Kurashige Y, Otani A, Sasahara M et al (2008) Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 146:513\u2013519","journal-title":"Am J Ophthalmol"},{"key":"1620_CR63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10384-010-0886-x","volume":"55","author":"E Akaza","year":"2011","unstructured":"Akaza E, Yuzawa M, Mori R (2011) Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 55:39\u201344","journal-title":"Jpn J Ophthalmol"},{"key":"1620_CR64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.iae.0000233647.78726.46","volume":"27","author":"Y Hirami","year":"2007","unstructured":"Hirami Y, Tsujikawa A, Otani A et al (2007) Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 27:335\u2013341","journal-title":"Retina"},{"key":"1620_CR65","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajo.2013.05.024","volume":"156","author":"A Oishi","year":"2013","unstructured":"Oishi A, Kojima H, Mandai M et al (2013) Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results. Am J Ophthalmol 156:644\u2013651","journal-title":"Am J Ophthalmol"},{"key":"1620_CR66","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajo.2005.12.002","volume":"141","author":"Y Ojima","year":"2006","unstructured":"Ojima Y, Tsujikawa A, Otani A et al (2006) Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy. Am J Ophthalmol 141:958\u2013960","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"1620_CR67","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/bjo.2006.092783","volume":"90","author":"H Imai","year":"2006","unstructured":"Imai H, Honda S, Nakanishi Y et al (2006) Different transitions of multifocal electroretinogram recording s between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy. Br J Ophthalmol 90(12):1524\u20131530","journal-title":"Br J Ophthalmol"},{"key":"1620_CR68","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2006.12.024","volume":"143","author":"K Musashi","year":"2007","unstructured":"Musashi K, Tsujikawa A, Hirami Y et al (2007) Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy. Am J Ophthalmol 143:883\u2013885","journal-title":"Am J Ophthalmol"},{"key":"1620_CR69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ajo.2012.02.019","volume":"154","author":"WK Lee","year":"2012","unstructured":"Lee WK, Kim KS, Kim W et al (2012) Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters. Am J Ophthalmol 154:355","journal-title":"Am J Ophthalmol"},{"key":"1620_CR70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcma.2013.10.012","volume":"77","author":"NW Fan","year":"2014","unstructured":"Fan NW, Lau LI, Chen SJ, Yang CS, Lee FL (2014) Comparison of the effect of reduced\u2013fluence photodynamic therapy with intravitreal bevacizumab and standard\u2013fluence alone for polypoidal choroidal vasculopathy. J Chin Med Assoc 77:101\u2013107","journal-title":"J Chin Med Assoc"},{"key":"1620_CR71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajo.2009.09.020","volume":"149","author":"A Yamashita","year":"2010","unstructured":"Yamashita A, Shiraga F, Shiragami C et al (2010) One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 149:465","journal-title":"Am J Ophthalmol"},{"key":"1620_CR72","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1167\/iovs.05-0354","volume":"47","author":"S Michels","year":"2006","unstructured":"Michels S, Hansmann F, Geitzenauer W, Schmidt-Erfurth U (2006) Influence of treatment parameters on selectivity of verteporfin therapy. Invest Ophthalmol Vis Sci 47:371\u2013376","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1620_CR73","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/IAE.0b013e318236e835","volume":"32","author":"F Ricci","year":"2012","unstructured":"Ricci F, Calabrese A, Regine F et al (2012) Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy. Retina 32:1280\u20131288","journal-title":"Retina"},{"key":"1620_CR74","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bjo.2003.032466","volume":"88","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Ogata N, Otsuji T et al (2004) Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 88:809\u2013815","journal-title":"Br J Ophthalmol"},{"key":"1620_CR75","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","volume":"141","author":"J-P Tong","year":"2006","unstructured":"Tong J-P, Chan W-M, Liu DTL et al (2006) Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 141:456\u2013462","journal-title":"Am J Ophthalmol"},{"key":"1620_CR76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjo.2008.150029","volume":"94","author":"GT Kokame","year":"2010","unstructured":"Kokame GT, Yeung L, Lai JC (2010) Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br J Ophthalmol 94:297\u2013301","journal-title":"Br J Ophthalmol"},{"key":"1620_CR77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0301-4738.109390","volume":"61","author":"JK Chhablani","year":"2013","unstructured":"Chhablani JK, Narula R, Narayanan R (2013) Intravitreal bevacizumab monotherapy for treatment-na\u00efve polypoidal choroidal vasculopathy. Indian J Ophthalmol 61:136\u2013138","journal-title":"Indian J Ophthalmol"},{"key":"1620_CR78","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ophtha.2015.05.024","volume":"122","author":"A Yamamoto","year":"2015","unstructured":"Yamamoto A, Okada AA, Kano M et al (2015) One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy. Ophthalmology 122:1866\u20131872","journal-title":"Ophthalmology"},{"key":"1620_CR79","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/IAE.0000000000000767","volume":"36","author":"C Hara","year":"2016","unstructured":"Hara C, Sawa M, Sayanagi K et al (2016) One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy. Retina 36:37\u201345","journal-title":"Retina"},{"key":"1620_CR80","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/eye.2011.324","volume":"26","author":"HJ Cho","year":"2012","unstructured":"Cho HJ, Kim JW, Lee DW et al (2012) Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy. Eye 26:426\u2013433","journal-title":"Eye"},{"key":"1620_CR81","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/IAE.0000000000000875","volume":"36","author":"J Qu","year":"2016","unstructured":"Qu J, Cheng Y, Li X et al (2016) Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup analysis of the Aurora study. Retina 36:926\u2013937","journal-title":"Retina"},{"key":"1620_CR82","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh A, Lee WK, Chen L-J et al (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453\u20131464","journal-title":"Retina"},{"key":"1620_CR83","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K et al (2017) Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 135:1206\u20131213","journal-title":"JAMA Ophthalmol"},{"key":"1620_CR84","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee WK, Iida T, Ogura Y et al (2018) Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial. JAMA Ophthalmol 136:786\u2013793","journal-title":"JAMA Ophthalmol"},{"key":"1620_CR85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajo.2012.08.002","volume":"155","author":"CM Gemmy Cheung","year":"2013","unstructured":"Gemmy Cheung CM, Yeo I, Li X, Mathur R, Lee SY, Chan CM et al (2013) Argon laser with and without anti\u2013vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. Am J Ophthalmol 155:295\u20133040","journal-title":"Am J Ophthalmol"},{"key":"1620_CR86","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10792-018-0900-8","volume":"39","author":"C Zuo","year":"2019","unstructured":"Zuo C, Zhang X, Li M, Peng Y, Mi L, Liu B et al (2019) Case series of coexistence of polypoidal choroidal vasculopathy with other rare fundus diseases. Int Ophthalmol 39:987\u2013990","journal-title":"Int Ophthalmol"},{"key":"1620_CR87","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10792-020-01299-3","volume":"40","author":"K Asano Shimizu","year":"2020","unstructured":"Asano Shimizu K, Asano S, Murata H et al (2020) Early changes of vascular lesions and responses to combined photodynamic therapy in patients with polypoidal choroidal vasculopathy. Int Ophthalmol 40:1335\u20131345","journal-title":"Int Ophthalmol"},{"key":"1620_CR88","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s10792-019-01082-z","volume":"3","author":"GC Calvo","year":"2019","unstructured":"Calvo GC, Reche Frutos J, Fern\u00e1ndez Vigo JI et al (2019) Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept. Int Ophthalmol 3:2441\u20132448","journal-title":"Int Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01620-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-020-01620-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01620-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T10:21:52Z","timestamp":1634725312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-020-01620-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1007\/s10792-020-01620-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"4 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}